G. Baxter

发表

BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties

F. King, T. Blackburn, G. Kennett, 1993, Psychopharmacology.

The effects of SB 204070, a highly potent and selective 5‐HT4 receptor antagonist, on guinea‐pig distal colon

G. Kennett, G. Sanger, L. Gaster, 1994, British journal of pharmacology.

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity.

I. Forbes, P. Ham, T. Blackburn, 1995, Journal of medicinal chemistry.

Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5‐HT2C/2B Receptor Antagonists.

Frank E. Blaney, S. Dabbs, D. Duckworth, 1997 .

Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonists.

S. Dabbs, D. Duckworth, I. Forbes, 1996, Journal of medicinal chemistry.

Endogenous ligands and inverse agonism.

G. Baxter, N. Tilford, 1995, Trends in pharmacological sciences.

Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery

R. A. Coleman, G. Baxter, J. Clayton, 1995, British journal of pharmacology.

In vitro characterization of prostanoid EP‐receptors in the non‐pregnant human myometrium

G. Baxter, J. Clayton, J. Senior, 1991, British journal of pharmacology.

Invitro characterization ofprostanoid EP-receptors inthe non-pregnant humanmyometrium

G. Baxter, J. Clayton, J. Senior, 1991 .

5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae

D. Clarke, D. Craig, G. Baxter, 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacological Analysis and Simulation of Ligand‐Receptor Interactions in Microsoft Excel™

W. P. Bowen, G. Baxter, N. Tilford, 1997 .

Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagus.

D. Clarke, G. Baxter, Gordon S. Baxter, 1992, European journal of pharmacology.

5‐HT2B receptors play a key role in mediating the excitatory effects of 5‐HT in human colon in vitro

D. Harmer, R. A. Coleman, R. Borman, 2002, British journal of pharmacology.

The adenosine receptor antagonist, 8‐phenyltheophylline, causes diuresis and saliuresis in the rat

G. Baxter, M. Collis, J. Keddie, 1986, The Journal of pharmacy and pharmacology.

Evidence that the intracellular effects of adenosine in the guinea-pig aorta are mediated by inosine.

G. Baxter, M. Collis, D. Palmer, 1986, European journal of pharmacology.

5-Hydroxytryptamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

G. Martin, J. Hensler, R. Hen, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

5-HT2 receptor subtypes: a family re-united?

F. Blaney, T. Blackburn, G. Kennett, 1995, Trends in pharmacological sciences.

In vitro characterization of prostanoid FP‐, DP‐, IP‐ and TP‐receptors on the non‐pregnant human myometrium

G. Baxter, J. Clayton, J. Senior, 1992, British journal of pharmacology.

Further characterization of 5‐hydroxytryptamine receptors (putative 5‐HT2B) in rat stomach fundus longitudinal muscle

T. Blackburn, G. Baxter, O. Murphy, 1994, British journal of pharmacology.

Mediation by 5‐hydroxytryptamine2B receptors of endothelium‐dependent relaxation in rat jugular vein

G. Baxter, N. Tilford, O. Murphy, 1995, British journal of pharmacology.

Pharmacological Properties of the Putative 5-HT4 Receptor in Guinea-Pig Ileum and Rat Oesophagus: Role in Peristalsis

D. Clarke, D. Craig, G. Baxter, 1991 .

EP4 prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries

R. Ravid, K. Clark, R. A. Coleman, 2004, British journal of pharmacology.

Effects of the 5‐HT2B receptor agonist, BW 723C86, on three rat models of anxiety

T. Blackburn, G. Kennett, B. Trail, 1996, British journal of pharmacology.

Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system

T. Blackburn, K. Fone, G. Baxter, 1997, Neuroscience.

In vitro and in vivo profile of SB 206553, a potent 5‐HT2C/5‐HT2B receptor antagonist with anxiolytic‐like properties

I. Forbes, P. Ham, T. Blackburn, 1996, British journal of pharmacology.

5-Hydroxytryptamine stimulates cyclic AMP formation in the tunica muscularis mucosae of the rat oesophagus via 5-HT4 receptors.

A. Ford, R. Eglen, D. Clarke, 1992, European journal of pharmacology.

N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist.

I. Forbes, G. E. Jones, V. Holland, 1995, Journal of medicinal chemistry.

5-Hydroxytryptamine receptors in GtoPdb v.2023.1

G. Martin, J. Hensler, B. Roth, 2023, IUPHAR/BPS Guide to Pharmacology CITE.

Novel discriminatory ligands for 5-HT2B receptors

G. Baxter, 1995, Behavioural Brain Research.

N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist.

P. Ham, G. Kennett, M. Wood, 1993, Journal of medicinal chemistry.